Literature DB >> 34519388

Cancer worry after facial nonmelanoma skin cancer resection and reconstruction: A 1-year prospective study.

Lucy J van Hensbergen1, Inge J Veldhuizen1,2, Erica H Lee2, Saskia Houterman3, Tjinta Brinkhuizen4, René R W J van der Hulst5, Maarten M Hoogbergen1.   

Abstract

OBJECTIVE: Nonmelanoma skin cancer (NMSC) is one of the most diagnosed cancers in the world, with the number of new occurrences rising every year. Most patients with facial skin cancer experience cancer-related worry. Yet, little is known about their worry during the period after cancer treatment. This study aimed to assess the long-term change of cancer worry after surgical treatment in patients with NMSC.
METHODS: Patients undergoing surgery for facial NMSC between December 2017 and March 2020 were asked to complete the FACE-Q Skin Cancer-Cancer Worry scale before (baseline), 3-month, and 1-year post-surgery.
RESULTS: A total of 151 patients completed the baseline and 3-month, and 99 (65.6%) the 1-year post-operative survey. A significant decrease in cancer worry score was seen between baseline and 3-month post-surgery (p < 0.001). No difference was found between the 3-month and 1-year post-surgery scores (p = 0.78). Less improvement in cancer worry was seen for patients who had one facial skin cancer in their medical history (p = 0.001) and patients who had a history of facial surgery (p < 0.001).
CONCLUSION: Post-surgery patients still experience cancer worry. Therefore, targeted counseling might be of value when coping with cancer-related concerns. Patients with a history of facial NMSC and patients with a history of facial surgery might benefit from additional counseling.
© 2022 John Wiley & Sons Ltd.

Entities:  

Keywords:  Mohs micrographic surgery; cancer worry; nonmelanoma skin cancer; oncology; patient reported outcome; psycho-oncology

Mesh:

Year:  2021        PMID: 34519388      PMCID: PMC9255639          DOI: 10.1002/pon.5810

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.955


  31 in total

1.  Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973.

Authors:  Esther de Vries; Marieke Louwman; Maarten Bastiaens; Frank de Gruijl; Jan Willem Coebergh
Journal:  J Invest Dermatol       Date:  2004-10       Impact factor: 8.551

2.  FACE-Q Skin Cancer Module for measuring patient-reported outcomes following facial skin cancer surgery.

Authors:  E H Lee; A F Klassen; S J Cano; K S Nehal; A L Pusic
Journal:  Br J Dermatol       Date:  2018-05-23       Impact factor: 9.302

3.  Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up.

Authors:  Eva van Loo; Klara Mosterd; Gertruud A M Krekels; Marieke H Roozeboom; Judith U Ostertag; Carmen D Dirksen; Peter M Steijlen; H A Martino Neumann; Patty J Nelemans; Nicole W J Kelleners-Smeets
Journal:  Eur J Cancer       Date:  2014-09-25       Impact factor: 9.162

Review 4.  Review of smartphone mobile applications for skin cancer detection: what are the changes in availability, functionality, and costs to users over time?

Authors:  Fleur W Kong; Caitlin Horsham; Alexander Ngoo; H Peter Soyer; Monika Janda
Journal:  Int J Dermatol       Date:  2020-09-02       Impact factor: 2.736

Review 5.  Problems and coping behaviour of facial cancer patients.

Authors:  M E Koster; J Bergsma
Journal:  Soc Sci Med       Date:  1990       Impact factor: 4.634

Review 6.  Importance of physical appearance in patients with skin cancer.

Authors:  Joseph F Sobanko; David B Sarwer; Zinta Zvargulis; Christopher J Miller
Journal:  Dermatol Surg       Date:  2015-02       Impact factor: 3.398

7.  Factors contributing to cancer worry in the skin cancer population.

Authors:  Nima Khoshab; Toral S Vaidya; Stephen Dusza; Kishwer S Nehal; Erica H Lee
Journal:  J Am Acad Dermatol       Date:  2019-10-01       Impact factor: 11.527

8.  To see or not to see: Impact of viewing facial skin cancer defects prior to reconstruction.

Authors:  Inge J Veldhuizen; Erica H Lee; Nicholas R Kurtansky; Lucy J van Hensbergen; Stephen W Dusza; Marleen C Hölscher; René R W J van der Hulst; Maarten J Ottenhof; Andrea L Pusic; Maarten M Hoogbergen
Journal:  Arch Dermatol Res       Date:  2021-01-30       Impact factor: 3.017

9.  Prevention versus early detection for long-term control of melanoma and keratinocyte carcinomas: a cost-effectiveness modelling study.

Authors:  Louisa Gordon; Catherine Olsen; David C Whiteman; Thomas M Elliott; Monika Janda; Adele Green
Journal:  BMJ Open       Date:  2020-02-26       Impact factor: 2.692

Review 10.  Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review.

Authors:  Ahmad Ousmen; Célia Touraine; Nina Deliu; Francesco Cottone; Franck Bonnetain; Fabio Efficace; Anne Brédart; Caroline Mollevi; Amélie Anota
Journal:  Health Qual Life Outcomes       Date:  2018-12-11       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.